ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR)
CUSIP: 04280A100
Q4 2016 13F Holders as of 31 Dec 2016
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 135,488,140
- Total 13F shares
- 25,470,006
- Share change
- -4,539,636
- Total reported value
- $39,473,542
- Put/Call ratio
- 254%
- Price per share
- $1.55
- Number of holders
- 77
- Value change
- -$54,918,365
- Number of buys
- 41
- Number of sells
- 44
Quarterly Holders Quick Answers
What is CUSIP 04280A100?
CUSIP 04280A100 identifies ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 04280A100:
Top shareholders of ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| OppenheimerFunds, Inc. |
13F
|
Company |
2.2%
|
3,000,000
|
$22,050,000 | — | 30 Sep 2016 | |
| QVT Financial LP |
13F
|
Company |
1.9%
|
2,556,256
|
$18,788,000 | — | 30 Sep 2016 | |
| BlackRock Fund Advisors |
13F
|
Company |
1.8%
|
2,490,393
|
$18,304,000 | — | 30 Sep 2016 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.8%
|
2,483,209
|
$18,252,000 | — | 30 Sep 2016 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.6%
|
2,159,973
|
$15,876,000 | — | 30 Sep 2016 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
1.4%
|
1,856,967
|
$13,649,000 | — | 30 Sep 2016 | |
| BlackRock Institutional Trust Company, N.A. |
13F
|
Company |
1.3%
|
1,715,221
|
$12,607,000 | — | 30 Sep 2016 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
1.1%
|
1,525,424
|
$11,212,000 | — | 30 Sep 2016 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.1%
|
1,492,159
|
$10,967,000 | — | 30 Sep 2016 | |
| STATE STREET CORP |
13F
|
Company |
1%
|
1,391,832
|
$10,233,000 | — | 30 Sep 2016 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
0.82%
|
1,116,777
|
$8,208,000 | — | 30 Sep 2016 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.7%
|
945,692
|
$6,951,000 | — | 30 Sep 2016 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.63%
|
847,458
|
$6,228,000 | — | 30 Sep 2016 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.51%
|
694,576
|
$5,104,000 | — | 30 Sep 2016 | |
| HILLHOUSE INVESTMENT MANAGEMENT, LTD. |
13F
|
Company |
0.5%
|
677,966
|
$4,983,000 | — | 30 Sep 2016 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.37%
|
506,565
|
$3,724,000 | — | 30 Sep 2016 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.35%
|
478,392
|
$3,516,000 | — | 30 Sep 2016 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.22%
|
293,449
|
$2,157,000 | — | 30 Sep 2016 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.2%
|
271,118
|
$1,993,000 | — | 30 Sep 2016 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.19%
|
257,200
|
$1,890,000 | — | 30 Sep 2016 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.19%
|
252,675
|
$1,856,000 | — | 30 Sep 2016 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
0.18%
|
240,176
|
$1,765,000 | — | 30 Sep 2016 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.18%
|
238,082
|
$1,750,000 | — | 30 Sep 2016 | |
| EverPoint Asset Management, LLC |
13F
|
Company |
0.15%
|
200,000
|
$1,470,000 | — | 30 Sep 2016 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.14%
|
185,299
|
$1,362,000 | — | 30 Sep 2016 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.12%
|
161,640
|
$1,190,000 | — | 30 Sep 2016 | |
| MORGAN STANLEY |
13F
|
Company |
0.11%
|
143,526
|
$1,054,000 | — | 30 Sep 2016 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.09%
|
127,806
|
$939,000 | — | 30 Sep 2016 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.08%
|
102,631
|
$754,000 | — | 30 Sep 2016 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.07%
|
100,000
|
$735,000 | — | 30 Sep 2016 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.07%
|
95,441
|
$701,000 | — | 30 Sep 2016 | |
| Swiss National Bank |
13F
|
Company |
0.07%
|
91,400
|
$672,000 | — | 30 Sep 2016 | |
| Emerald Acquisition Ltd. |
13F
|
Company |
0.06%
|
87,598
|
$644,000 | — | 30 Sep 2016 | |
| SHELL ASSET MANAGEMENT CO |
13F
|
Company |
0.05%
|
73,686
|
$542,000 | — | 30 Sep 2016 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.05%
|
71,300
|
$524,000 | — | 30 Sep 2016 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.05%
|
62,713
|
$461,000 | — | 30 Sep 2016 | |
| Cutler Group LLC / CA |
13F
|
Company |
0.05%
|
61,428
|
$451,000 | — | 30 Sep 2016 | |
| First Allied Advisory Services, Inc. |
13F
|
Company |
0.05%
|
61,000
|
$448,000 | — | 30 Sep 2016 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.04%
|
59,832
|
$440,000 | — | 30 Sep 2016 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.04%
|
54,400
|
$400,000 | — | 30 Sep 2016 | |
| FALCON POINT CAPITAL, LLC |
13F
|
Company |
0.04%
|
58,398
|
$339,000 | — | 30 Sep 2016 | |
| ProShare Advisors LLC |
13F
|
Company |
0.03%
|
44,251
|
$325,000 | — | 30 Sep 2016 | |
| VIRTUS ADVISERS, LLC |
13F
|
Company |
0.03%
|
43,272
|
$318,000 | — | 30 Sep 2016 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.03%
|
43,194
|
$317,000 | — | 30 Sep 2016 | |
| Moors & Cabot, Inc. |
13F
|
Company |
0.03%
|
40,270
|
$292,000 | — | 30 Sep 2016 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.03%
|
38,458
|
$283,000 | — | 30 Sep 2016 | |
| Nationwide Fund Advisors |
13F
|
Company |
0.03%
|
38,161
|
$280,000 | — | 30 Sep 2016 | |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.03%
|
37,425
|
$275,000 | — | 30 Sep 2016 | |
| METROPOLITAN LIFE INSURANCE CO/NY |
13F
|
Company |
0.03%
|
36,692
|
$270,000 | — | 30 Sep 2016 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.03%
|
36,002
|
$265,000 | — | 30 Sep 2016 |
Institutional Holders of ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR) as of Q4 2016
As of 31 Dec 2016,
ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR) was held by
77 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,470,006 shares.
The largest 10 holders included
OppenheimerFunds, Inc., BlackRock Fund Advisors, VANGUARD GROUP INC, QVT Financial LP, PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C., BlackRock Institutional Trust Company, N.A., MILLENNIUM MANAGEMENT LLC, STATE STREET CORP, PERCEPTIVE ADVISORS LLC, and NORTHERN TRUST CORP.
This page lists
77
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2016 vs Q3 2016 Across Filers
Q3 2016 holders
94
Q4 2016 holders
77
Holder diff
-17
| Investor | Q3 2016 Shares | Q4 2016 Shares | Share Diff | Share Chg % | Q3 2016 Value $ | Q4 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.